Accelerated TMS for MDD

Part of paid clinical trials in New York, New York.

Sponsor
Neuronetics
Study ID
NCT07147218
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
15 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TMS — DEVICE
    transcranial magnetic stimulation - DASH 36 treatment delivered in 5 days

Study Details

An open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).

Key Dates

Start date
Aug 21, 2025
Status verified
Nov 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Treatment Arm
    Patients will receive 5 consecutive calendar days of treatments with 6-8 treatments per day for a total of 36 treatments

Primary Outcome Measure

Change in MADRS score from baseline to post-treatment. [ Time Frame: 2 weeks ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Brighter NeurotherapeuticsNew YorkNew York10010
Grant Brenner, MD
TMS of the CarolinasCharlotteNorth Carolina28210
Terry Wise
New chapter TMSSpokaneWashington99202
Kiira Tietjen, DNP

Find similar trials in New York, NY

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Brighter Neurotherapeutics· New York, NYTMS of the Carolinas· Charlotte, NCNew chapter TMS· Spokane, WA

Related Studies